Search research articles
Contact Us
Filters
Showing results (11-20 of 117) with videos related to
Page
of 12
Sort By:
The Journal of Experimental Biology
|
December 17, 2009
Epigenetics and transgenerational transfer: a physiological perspective
D H Ho, W W Burggren
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1975
Reappearance of dihydrofolate reductase in rodent tissues following methotrexate administration
D H Ho, W C Werkheiser
Anticancer Research
|
May 1, 1990
Enzymatic conversion of 5-fluoro-2'-deoxyuridine to 5-fluorouracil or 5-fluoro-2'-deoxyuridine 5'-monophosphate in human tissues
M Uchida, N Brown, D H Ho
Antimicrobial Agents and Chemotherapy
|
September 1, 1990
Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer
K V Rolston, M Messer, D H Ho
Cancer Research
|
December 1, 1972
The effects of arabinosylcytosine on cultured human lymphoma cells
B Drewinko, D H Ho, S C Barranco
The American Journal of Medicine
|
July 25, 1988
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital
G P Bodey, D H Ho, L Elting
The Journal of Antimicrobial Chemotherapy
|
February 1, 1986
In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin
K V Rolston, B LeBlanc, D H Ho
Diagnostic Microbiology and Infectious Disease
|
July 1, 1989
In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients
G P Bodey, P Miller, D H Ho
Antimicrobial Agents and Chemotherapy
|
February 1, 1985
In vitro studies of BMY-28142, a new broad-spectrum cephalosporin
G P Bodey, D H Ho, B LeBlanc
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 1, 1989
In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients
K Rolston, D H Ho, G P Bodey
Page
of 12
Search research articles
Search
Showing results (11-20 of 117) with videos related to
Sort By:
Page
of 12
The Journal of Experimental Biology
|
December 17, 2009
Epigenetics and transgenerational transfer: a physiological perspective
D H Ho, W W Burggren
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1975
Reappearance of dihydrofolate reductase in rodent tissues following methotrexate administration
D H Ho, W C Werkheiser
Anticancer Research
|
May 1, 1990
Enzymatic conversion of 5-fluoro-2'-deoxyuridine to 5-fluorouracil or 5-fluoro-2'-deoxyuridine 5'-monophosphate in human tissues
M Uchida, N Brown, D H Ho
Antimicrobial Agents and Chemotherapy
|
September 1, 1990
Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer
K V Rolston, M Messer, D H Ho
Cancer Research
|
December 1, 1972
The effects of arabinosylcytosine on cultured human lymphoma cells
B Drewinko, D H Ho, S C Barranco
The American Journal of Medicine
|
July 25, 1988
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital
G P Bodey, D H Ho, L Elting
The Journal of Antimicrobial Chemotherapy
|
February 1, 1986
In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin
K V Rolston, B LeBlanc, D H Ho
Diagnostic Microbiology and Infectious Disease
|
July 1, 1989
In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients
G P Bodey, P Miller, D H Ho
Antimicrobial Agents and Chemotherapy
|
February 1, 1985
In vitro studies of BMY-28142, a new broad-spectrum cephalosporin
G P Bodey, D H Ho, B LeBlanc
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 1, 1989
In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients
K Rolston, D H Ho, G P Bodey
Page
of 12